GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Total Long-Term Liabilities

Y-Biologics (XKRX:338840) Total Long-Term Liabilities : ₩1,368 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Y-Biologics's Total Long-Term Liabilities for the quarter that ended in Jun. 2024 was ₩1,368 Mil.

Y-Biologics Total Long-Term Liabilities Historical Data

The historical data trend for Y-Biologics's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Total Long-Term Liabilities Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial 5,591.02 5,443.11 3,594.57 834.06 1,377.73

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 819.84 1,326.35 1,377.73 1,379.70 1,367.62

Y-Biologics Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Y-Biologics Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Total Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines